शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ALIVUSNSEAlivus Life Sciences Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 22 Jan, 2026 · 13:50 IST

Alivus Life Sciences Q3 FY26 results: revenue up 4.8% YoY, PAT rises 9.7%

ALIVUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.9%Reaction day
₹864.90
prior close
₹848.90
announcement price
In-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.6%-0.6% vs market
Pharmaceuticals peers, median of 156sector+1.2%-0.3% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.6
10m
+0.3
15m
+0.5
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.9+1.6-0.6+1.2-0.3
Next day
+1.5-0.6+2.1+0.0+1.5
2d
+2.6-0.5+3.0-0.7+3.2
3d
+8.1+1.5+6.6+0.2+7.9
4d
+8.2+1.1+7.1-0.3+8.6
5d
+10.8+3.0+7.8+0.1+10.7
1w
+9.6+5.5+4.1+2.4+7.2
15d
+6.2+6.1+0.1+2.7+3.5
1m
+4.2+5.1-0.9+1.2+3.0
2m
+8.0-8.0+16.0-8.5+16.6
3m
+22.0+10.9+11.0+3.4+18.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alivus Life Sciences reported Q3 FY26 revenue from operations of 672.89 crore, up 4.8% YoY from 641.84 crore. PAT rose 9.7% to 150.26 crore from 136.96 crore. For nine months, revenue grew to 1,862.72 crore versus 1,737.34 crore, and PAT climbed to 401.82 crore from 343.76 crore. The company booked an exceptional item of 25.66 crore for the statutory impact of new Labour Codes covering gratuity and leave encashment. Auditor Walker Chandiok issued an unmodified limited review report.

Likely market impact

Steady YoY growth in revenue and profit despite a one-time labour code charge. Positive earnings momentum for shareholders.